GI-1345 Medicina Neonatal e do Desarrollo
GI-1345
![Foto de GI-1345 Medicina Neonatal e do Desarrollo](/img/grupo.png)
![Foto de Hospital Virgen del Camino](/img/noimage_org.png)
Hospital Virgen del Camino
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Hospital Virgen del Camino (17)
2019
-
Cohort study showed that growth rate increment has not been enough to prevent growth retardation of preterm infants and raised concerns about unbalanced growth
Acta Paediatrica, International Journal of Paediatrics, Vol. 108, Núm. 10, pp. 1793-1800
-
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
Medicine (United States), Vol. 98, Núm. 39
-
The Effect of Morbidity and Sex on Postnatal Growth of Very Preterm Infants: A Multicenter Cohort Study
Neonatology, Vol. 115, Núm. 4, pp. 348-354
-
The impact of postnatal systemic steroids on the growth of preterm infants: A multicenter cohort study
Nutrients, Vol. 11, Núm. 11
2017
-
A selective screening program for the early detection of mucopolysaccharidosis: Results of the FIND project-A 2-year follow-up study
Medicine (United States), Vol. 96, Núm. 19
-
Circulating antibody 1 and 2 years after vaccination with the 13-valent pneumococcal conjugate vaccine in preterm compared with term infants
Pediatric Infectious Disease Journal, Vol. 36, Núm. 3, pp. 326-332
-
Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease
Human Mutation, Vol. 38, Núm. 6, pp. 678-691
2016
-
Molecular epidemiology, genotype-phenotype correlation and BH 4 responsiveness in Spanish patients with phenylketonuria
Journal of Human Genetics, Vol. 61, Núm. 8, pp. 731-744
2015
-
13-Valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants
Pediatrics, Vol. 135, Núm. 4, pp. e876-e886
-
6R-tetrahydrobiopterin treated PKU patients below 4years of age: Physical outcomes, nutrition and genotype
Molecular Genetics and Metabolism, Vol. 115, Núm. 1, pp. 10-16
-
Corrigendum to "Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU" [Mol. Genet. Metab. 109 (2013) 331-338]
Molecular Genetics and Metabolism
-
Phenylketonuria's impact on physical growth in a Spanish cohort
Phenylalanine: Dietary Sources, Functions and Health Effects (Nova Science Publishers, Inc.), pp. 27-48
2014
-
Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients
Clinical Nutrition, Vol. 33, Núm. 4, pp. 702-717
2013
-
Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU
Molecular Genetics and Metabolism, Vol. 109, Núm. 4, pp. 331-338
2010
-
Efectividad de palivizumab en la prevención de la infección por el virus respiratorio sincitial en prematuros de 321 a 35° semanas de gestación en España
Acta Pediatrica Espanola, Vol. 68, Núm. 1, pp. 13-18
-
Management of phenylketonuria in Europe: Survey results from 19 countries
Molecular Genetics and Metabolism, Vol. 99, Núm. 2, pp. 109-115
2009
-
Genetic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin deficiency type C (cblC) with homocystinuria (MMACHC)
Human Mutation, Vol. 30, Núm. 11, pp. 1558-1566